Published Manuscripts (2005)
, Palmer AJ, Lammert M, Nicklasson L, Foos V, Roze S. Long-term clinical and cost outcomes of treatment with biphasic insulin aspart 30/70 versus insulin glargine in insulin naive type 2 diabetes patients: cost-effectiveness analysis in the UK setting. Current Medical Research and Opinion 2005; 21(12): 2063-71
Roze S, , Zakrzewska KE, Palmer AJ. Health-economic comparison of continuous subcutaneous insulin infusion with multiple daily injection for the treatment of type 1 diabetes in the UK. Diabetic Medicine 2005; 22(9): 1239-45
Ray JA, , Secnik K, Oglesby AK, Cordony A, Gordois A, Davey P, Palmer AJ. Review of the cost of diabetes complications in Australia, Canada, France, Germany, Italy and Spain. Current Medical Research and Opinion 2005; 21(10): 1617-29
Minshall ME, Roze S, Palmer AJ, , Foos V, Ray J, Graham C. Treating diabetes to accepted standards of care: a 10-year projection of the estimated economic and health impact in patients with type 1 and type 2 diabetes mellitus in the United States. Clinical Therapeutics 2005; 27(6): 940-50
Palmer AJ, Tucker DM, , Roze S, Gabriel S, Cordonnier DJ. Cost-effectiveness of irbesartan in diabetic nephropathy: a systematic review of published studies. Nephrology Dialysis Transplantation 2005; 20(6): 1103-9
Palmer AJ, , Roze S, Lammert M, Spiesser J, Gabriel S. Overview of costs of stroke from published, incidence-based studies spanning 16 industrialized countries. Current Medical Research and Opinion 2005; 21(1): 19-26
Dial with SkypeOut